Replies to post #324934 on Avid Bioservices Inc (CDMO)

[shipbuilder]

"...divesting the bulk of it's legacy R&D assets."

What of the IP remains with CDMO and why is this information not made explicit?


This company has never done anything but beat up it's shareholders. And they've done this with impunity.

[biopharm]

It appears they must have sold off Exsomes, biomarkers, etc in this "deal".

We can't be sure since Lias only said "bulk.."

Bulk = greater part ...but the least bulky part of IP may be worth the bulk of the assessment value vs the rest

Hence....we need the Roth opinion and see how many key expert witnesses they used for their due diligence and ROTH typically gets paid for each KOL they use to assess values and if they were not allowed to do so ....

We have failure of Fiduciary Duties .....which brings us full circle back to needing to view the full contract with Oncologie

The finger pointing has already begun

[vinmantoo]

It appears they must have sold off Exsomes, biomarkers, etc in this "deal".

There was so little data generated by PPHM on exosomes and it was thrown out there immediately after yet another Bavi failure. That makes it clear that PPHM exosomes have little to no value regardless of who owns them.

I wonder how long it will take for CDMO to collect the $8 million they were promised by a company that apparently has no track record and has just been formed.